9G2 Stock Overview

An investment holding company, provides medical diagnostics and treatments, and radiation therapy and medical oncology services in Singapore. More details

9G2 fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	1/6
Dividends	0/6

Rewards

Revenue grew by 2.5% over the past year

Risk Analysis

Shares are highly illiquid

Has less than 1 year of cash runway

Does not have a meaningful market cap (SGD58M)

My Notes

Capture your thoughts, links and company narrative

Singapore Institute of Advanced Medicine Holdings Ltd. Competitors

HC Surgical Specialists

Catalist:1B1

S$43.1m

Cordlife Group

SGX:P8A

S$39.7m

Medinex

Catalist:OTX

S$29.2m

Alliance Healthcare Group

Catalist:MIJ

S$26.6m

Price History & Performance

Summary of share price highs, lows and changes for Singapore Institute of Advanced Medicine Holdings
Historical stock prices
Current Share Price	S$0.055
52 Week High	S$0.20
52 Week Low	S$0.049
Beta	0
1 Month Change	-15.38%
3 Month Change	-35.29%
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-71.05%

Recent updates

Shareholder Returns

	9G2	SG Healthcare	SG Market
7D	-8.3%	-1.9%	-1.3%
1Y	n/a	-13.3%	14.0%

Return vs Industry: Insufficient data to determine how 9G2 performed against the SG Healthcare industry.

Return vs Market: Insufficient data to determine how 9G2 performed against the SG Market.

Price Volatility

Is 9G2's price volatile compared to industry and market?
9G2 volatility
9G2 Average Weekly Movement	n/a
Healthcare Industry Average Movement	6.0%
Market Average Movement	4.4%
10% most volatile stocks in SG Market	13.3%
10% least volatile stocks in SG Market	2.0%

Stable Share Price: 9G2's share price has been volatile over the past 3 months compared to the SG market.

Volatility Over Time: Insufficient data to determine 9G2's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2011	n/a	Shih Kien Djeng	www.advancedmedicine.sg

Singapore Institute of Advanced Medicine Holdings Ltd., an investment holding company, provides medical diagnostics and treatments, and radiation therapy and medical oncology services in Singapore. The company offers medical diagnostics and treatments, including cancer-related diagnostics and theranostics treatments, general diagnostics and health screening, and aesthetic services; and radiation therapy and medical oncology services comprise proton beam therapy, photon radiation therapy, and medical oncology services. It provides clinic and imaging services; manufactures medical research and clinical diagnostic instruments and supplies; and sells pharmaceuticals, surgical products, and consumables.

Singapore Institute of Advanced Medicine Holdings Ltd. Fundamentals Summary

How do Singapore Institute of Advanced Medicine Holdings's earnings and revenue compare to its market cap?
9G2 fundamental statistics
Market cap	S$57.65m
Earnings (TTM)	-S$37.44m
Revenue (TTM)	S$16.65m

3.5x

P/S Ratio

-1.5x

P/E Ratio

Is 9G2 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
9G2 income statement (TTM)
Revenue	S$16.65m
Cost of Revenue	S$7.83m
Gross Profit	S$8.82m
Other Expenses	S$46.26m
Earnings	-S$37.44m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-0.036
Gross Margin	52.99%
Net Profit Margin	-224.91%
Debt/Equity Ratio	16.5%

How did 9G2 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/20 11:33
End of Day Share Price	2024/12/20 00:00
Earnings	2024/06/30
Annual Earnings	2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Singapore Institute of Advanced Medicine Holdings Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution